サマリー

消化器疾患治療薬の世界市場 2022-2026 年
Technavioは消化器疾患治療薬市場を監視しており、2022-2026年の間に16億ドルの成長が見込まれ、予測期間中にCAGR 6.68%で加速しています。当レポートでは、消化器疾患治療薬市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、消化器疾患の発生率の増加、新製品の上市、生物学的製剤や標的治療薬の需要増によって牽引されています。
消化器疾患治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの消化器疾患治療薬市場は、以下のように区分されています。
製品別
- 抗炎症剤および免疫抑制剤
- 酸中和剤
- その他の治療薬
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、強力な製品パイプラインが、今後数年間の胃腸疾患治療薬市場の成長を促進する主要な理由の1つであることを確認しています。また、胃腸の研究調査への資金提供や、在宅療法と相まってセルフメディケーションの増加も、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。消化器疾患治療薬市場に関する当レポートは、以下の分野を対象としています。
- 消化器疾患治療薬市場のサイジング
- 消化器系疾患治療薬市場の予測
- 消化器疾患治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Abbott Laboratories、AbbVie Inc、AstraZeneca Plc、Bausch Health Co Inc、Bayer AG、Biogen Inc、Boston Scientific Corp.、 C. H. Boehringer Sohn AG and Co.KG、エーザイ株式会社エーザイ株式会社、イーライリリー・アンド・カンパニー株式会社、イヴォーク・ファーマ株式会社、グラクソ・スミスクライン・ピーエルシー、ジョンソン・アンド・ジョンソン株式会社、メルク・アンド・カンパニー株式会社、エーザイ株式会社、株式会社エヌ・ティ・ティ・ドコモ、株式会社エヌ・ティ・ティ・ドコモInc.、Novartis AG、Olympus Corp.、OVESCO ENDOSCOPY AG、Pfizer Inc.、Takeda Pharmaceutical Co.Ltd.、武田薬品工業株式会社、UCB SAです。また、消化器疾患治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/gastrointestinal-diseases-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 Anti-inflammatory and immunosuppressors - Market size and forecast 2021-2026
o Exhibit 28: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2021-2026 (%)
o 5.4 Acid neutralizers - Market size and forecast 2021-2026
o Exhibit 32: Chart on Acid neutralizers - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Acid neutralizers - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Acid neutralizers - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Acid neutralizers - Year-over-year growth 2021-2026 (%)
o 5.5 Other therapeutics - Market size and forecast 2021-2026
o Exhibit 36: Chart on Other therapeutics - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Other therapeutics - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Other therapeutics - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Other therapeutics - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Drug Class
o Exhibit 40: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Japan - Market size and forecast 2021-2026
o Exhibit 66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 89: Abbott Laboratories - Overview
o Exhibit 90: Abbott Laboratories - Business segments
o Exhibit 91: Abbott Laboratories - Key news
o Exhibit 92: Abbott Laboratories - Key offerings
o Exhibit 93: Abbott Laboratories - Segment focus
o 10.4 AbbVie Inc.
o Exhibit 94: AbbVie Inc. - Overview
o Exhibit 95: AbbVie Inc. - Product / Service
o Exhibit 96: AbbVie Inc. - Key offerings
o 10.5 AstraZeneca Plc
o Exhibit 97: AstraZeneca Plc - Overview
o Exhibit 98: AstraZeneca Plc - Product / Service
o Exhibit 99: AstraZeneca Plc - Key news
o Exhibit 100: AstraZeneca Plc - Key offerings
o 10.6 Bausch Health Co Inc
o Exhibit 101: Bausch Health Co Inc - Overview
o Exhibit 102: Bausch Health Co Inc - Business segments
o Exhibit 103: Bausch Health Co Inc - Key news
o Exhibit 104: Bausch Health Co Inc - Key offerings
o Exhibit 105: Bausch Health Co Inc - Segment focus
o 10.7 C. H. Boehringer Sohn AG and Co. KG
o Exhibit 106: C. H. Boehringer Sohn AG and Co. KG - Overview
o Exhibit 107: C. H. Boehringer Sohn AG and Co. KG - Business segments
o Exhibit 108: C. H. Boehringer Sohn AG and Co. KG - Key news
o Exhibit 109: C. H. Boehringer Sohn AG and Co. KG - Key offerings
o Exhibit 110: C. H. Boehringer Sohn AG and Co. KG - Segment focus
o 10.8 GlaxoSmithKline Plc
o Exhibit 111: GlaxoSmithKline Plc - Overview
o Exhibit 112: GlaxoSmithKline Plc - Business segments
o Exhibit 113: GlaxoSmithKline Plc - Key news
o Exhibit 114: GlaxoSmithKline Plc - Key offerings
o Exhibit 115: GlaxoSmithKline Plc - Segment focus
o 10.9 Johnson and Johnson
o Exhibit 116: Johnson and Johnson - Overview
o Exhibit 117: Johnson and Johnson - Business segments
o Exhibit 118: Johnson and Johnson - Key news
o Exhibit 119: Johnson and Johnson - Key offerings
o Exhibit 120: Johnson and Johnson - Segment focus
o 10.10 Merck and Co. Inc.
o Exhibit 121: Merck and Co. Inc. - Overview
o Exhibit 122: Merck and Co. Inc. - Business segments
o Exhibit 123: Merck and Co. Inc. - Key news
o Exhibit 124: Merck and Co. Inc. - Key offerings
o Exhibit 125: Merck and Co. Inc. - Segment focus
o 10.11 Takeda Pharmaceutical Co. Ltd.
o Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 127: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 128: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 129: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 10.12 UCB SA
o Exhibit 130: UCB SA - Overview
o Exhibit 131: UCB SA - Product / Service
o Exhibit 132: UCB SA - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations
o disease


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on Anti-inflammatory and immunosuppressors - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Anti-inflammatory and immunosuppressors - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Anti-inflammatory and immunosuppressors - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Anti-inflammatory and immunosuppressors - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Acid neutralizers - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Acid neutralizers - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Acid neutralizers - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Acid neutralizers - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Other therapeutics - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Other therapeutics - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Other therapeutics - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Other therapeutics - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Drug Class ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Abbott Laboratories - Overview
Exhibits90: Abbott Laboratories - Business segments
Exhibits91: Abbott Laboratories - Key news
Exhibits92: Abbott Laboratories - Key offerings
Exhibits93: Abbott Laboratories - Segment focus
Exhibits94: AbbVie Inc. - Overview
Exhibits95: AbbVie Inc. - Product / Service
Exhibits96: AbbVie Inc. - Key offerings
Exhibits97: AstraZeneca Plc - Overview
Exhibits98: AstraZeneca Plc - Product / Service
Exhibits99: AstraZeneca Plc - Key news
Exhibits100: AstraZeneca Plc - Key offerings
Exhibits101: Bausch Health Co Inc - Overview
Exhibits102: Bausch Health Co Inc - Business segments
Exhibits103: Bausch Health Co Inc - Key news
Exhibits104: Bausch Health Co Inc - Key offerings
Exhibits105: Bausch Health Co Inc - Segment focus
Exhibits106: C. H. Boehringer Sohn AG and Co. KG - Overview
Exhibits107: C. H. Boehringer Sohn AG and Co. KG - Business segments
Exhibits108: C. H. Boehringer Sohn AG and Co. KG - Key news
Exhibits109: C. H. Boehringer Sohn AG and Co. KG - Key offerings
Exhibits110: C. H. Boehringer Sohn AG and Co. KG - Segment focus
Exhibits111: GlaxoSmithKline Plc - Overview
Exhibits112: GlaxoSmithKline Plc - Business segments
Exhibits113: GlaxoSmithKline Plc - Key news
Exhibits114: GlaxoSmithKline Plc - Key offerings
Exhibits115: GlaxoSmithKline Plc - Segment focus
Exhibits116: Johnson and Johnson - Overview
Exhibits117: Johnson and Johnson - Business segments
Exhibits118: Johnson and Johnson - Key news
Exhibits119: Johnson and Johnson - Key offerings
Exhibits120: Johnson and Johnson - Segment focus
Exhibits121: Merck and Co. Inc. - Overview
Exhibits122: Merck and Co. Inc. - Business segments
Exhibits123: Merck and Co. Inc. - Key news
Exhibits124: Merck and Co. Inc. - Key offerings
Exhibits125: Merck and Co. Inc. - Segment focus
Exhibits126: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits127: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits128: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits129: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits130: UCB SA - Overview
Exhibits131: UCB SA - Product / Service
Exhibits132: UCB SA - Key offerings
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations